DEUTSCHE BANK AG\ - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 63 filers reported holding SOLENO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 4.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$54,000
-40.0%
42,716
-7.8%
0.00%
Q4 2020$90,000
+5.9%
46,344
+37.1%
0.00%
Q3 2020$85,000
+150.0%
33,806
+119.6%
0.00%
Q2 2020$34,000
+385.7%
15,395
+221.4%
0.00%
Q3 2019$7,000
-56.2%
4,790
-19.0%
0.00%
Q2 2019$16,000
-77.1%
5,910
-82.8%
0.00%
Q1 2019$70,00034,400
+39900.0%
0.00%
Q3 2018$0
-100.0%
86
-99.2%
0.00%
Q2 2018$26,00011,2160.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,438,060$5,266,0001.15%
Vivo Capital, LLC 4,359,683$9,417,0000.95%
Trellus Management Company, LLC 152,829$330,0000.48%
SABBY MANAGEMENT, LLC 755,312$1,631,0000.21%
683 Capital Management, LLC 844,112$1,823,0000.12%
SHIKIAR ASSET MANAGEMENT INC 30,300$65,0000.02%
SECTORAL ASSET MANAGEMENT INC 21,587$47,0000.01%
Kepos Capital LP 37,591$81,0000.00%
DEUTSCHE BANK AG\ 86$00.00%
PANAGORA ASSET MANAGEMENT INC 11,851$26,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders